Spinal needle

DEVICE4 trials

Sponsors

Johns Hopkins University, Cairo University, Becton, Dickinson and Company, Nyanza Reproductive Health Society

Conditions

AnalgesiaAnesthesiaAnesthesia, ObestetricAnhydramniosFetal Renal AnomalyIncomplete MiscarriageLower Urinary Tract Obstructive SyndromeLung Hypoplasia

Phase 1

Renal Anhydramnios Fetal Therapy

CompletedNCT03101891

Johns Hopkins UniversityAnhydramnios, Fetal Renal Anomaly, Lower Urinary Tract Obstructive Syndrome +4

Start: 2018-12-21End: 2026-02-27Updated: 2026-07-01

Phase 3

Validation of Chloe SED, a reusable, low-cost syringe extension device for the provision of paracervical analgesia during gynecologic procedures

Active, not recruitingPACTR202111738348757

Nyanza Reproductive Health SocietyIncomplete Miscarriage

Start: 2021-12-01Target: 210Updated: 2026-08-03

Unknown Phase

Regional Anesthesia of Cesarean Section

CompletedNCT03556267

Cairo UniversityAnesthesia, Obestetric

Start: 2019-08-14End: 2021-02-14Updated: 2021-02-16

Prospective Clinical Evaluation of BD Spinal Needles

CompletedNCT05214560

Becton, Dickinson and CompanyAnalgesia, Anesthesia

Start: 2022-02-14End: 2022-07-22Updated: 2024-08-19

Related Papers

Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure

JAMA2026-07-01

Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis

JAMA2023-12-0549 citations

Design and Protocol of the Renal Anhydramnios Fetal Therapy (RAFT) Trial.

2022-07-3019 citations

Amnioinfusions to Treat Early Onset Anhydramnios Caused by Renal Anomalies: Background and Rationale for the Renal Anhydramnios Fetal Therapy Trial.

2019-03-2130 citations